Skip to main content
. 2021 Dec 5;13(12):2087. doi: 10.3390/pharmaceutics13122087

Table 1.

Particle size analysis of the prepared NC dispersions.

Stabilizer Concentration
(% w/v)
Size (nm) PDI
PVP K25 0.1 578.53 ± 16.98 0.32 ± 0.06
0.15 401.20 ± 16.48 * 0.25 ± 0.02
0.3 466.47 ± 11.34 *# 0.30 ± 0.03
0.6 662.57 ± 22.70 *#@ 0.55 ± 0.02
PLX188 0.1 401.66 ± 54.50 0.42 ± 0.11
0.15 350.20 ± 1.79 * 0.24 ± 0.01
0.3 353.30 ± 2.50 * 0.22 ± 0.01
0.6 528.03 ± 3.53 *#@ 0.36 ± 0.03
SDS 0.1 968.03 ± 66.70 0.49 ± 0.05
0.15 828.27 ± 54.36 * 0.42 ± 0.03
0.3 527.33 ± 10.01 *# 0.40 ± 0.05
0.6 832.09 ± 21.87 *@ 0.22 ± 0.05
CS/PLX188 0.02/0.15 443.13 ± 6.05 $ 0.35 ± 0.02
0.04/0.15 368.93 ± 0.47 * 0.23 ± 0.01
0.06/0.15 453.17± 11.71 #$ 0.25 ± 0.04

Data are presented as the mean ± SD (n = 3). The statistical analysis was performed at p < 0.05. *, #, $, and @ indicate significant differences. Regarding PVP K25, SDS, and PLX188: * vs. 0.1% w/v; # vs. 0.15% w/v; @ vs. 0.3% w/v. Regarding CS/PLX188 combinations: * vs. 0.02/0.15 (% w/v); # vs. 0.04%/0.15 (% w/v); $ vs. 0.15% w/v PLX188 alone. PVP K25, poly vinyl pyrrolidone K25; PLX188, poloxamer 188; SDS, sodium dodecyl sulfate; CS, chitosan; PDI, poly dispersity index.